Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CPN1 | P15169 | 6/20 | 0.44 |
| ▸ | CPB2 | Q96IY4 | 6/20 | 0.44 |
| ▸ | THRB | P10828 | 1/20 | 0.36 |
| ▸ | TSHR | P16473 | 2/20 | 0.34 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.34 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.33 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.33 |
| ▸ | TP53 | P04637 | 1/20 | 0.33 |
| ▸ | CHRNB2 | P17787 | 1/20 | 0.33 |
| ▸ | CHRNB4 | P30926 | 1/20 | 0.33 |
| ▸ | CHRNA3 | P32297 | 1/20 | 0.33 |
| ▸ | CHRNA4 | P43681 | 1/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.32 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4366394 | 0.84 | CPN1 (0.36) | CPN1CPB2THRBTSHRHSD17B10 | |
| SCHEMBL5982259 | 0.82 | CPB2 (0.44) | CPN1CPB2TSHRHSD17B10 | |
| SCHEMBL28720058 | 0.81 | THRB (0.37) | THRBTSHRSMN1; SMN2CA14TP53 | |
| SCHEMBL5493664 | 0.79 | THRB (0.36) | CPN1CPB2THRBTSHRSMN1; SMN2 | |
| SCHEMBL27866752 | 0.76 | CHRNB2 (0.38) | THRBTSHRSMN1; SMN2CA14TP53 | |
| SCHEMBL28720037 | 0.75 | THRB (0.33) | THRBSMN1; SMN2CA14TP53CHRNB2 | |
| SCHEMBL1076982 | 0.75 | CPN1 (0.41) | CPN1CPB2TSHRHSD17B10CHRNB2 | |
| SCHEMBL13271016 | 0.73 | THRB (0.42) | THRBTSHRSMN1; SMN2TP53MEN1 | |
| SCHEMBL1972762 | 0.73 | THRB (0.42) | THRBTSHRSMN1; SMN2CA14TP53 | |
| SCHEMBL13950782 | 0.73 | THRB (0.42) | THRBTSHRSMN1; SMN2TP53MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 29 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2008129562-A2 | AN IMPROVED PROCESS FOR THE PREPARATION OF STABLE AMORPHOUS ATORVASTATIN HEMI CALCIUM AND THEIR SALTS THEREOF | MOREPEN LABORATORIES LIMITED (IN) | 2008-10-30 | — | — | WO | claimed |
| WO-2008062478-A2 | IMPROVED PROCESS FOR PURE MONTELUKAST SODIUM THROUGH PURE INTERMEDIATES AS WELL AS NOVEL AMINE SALTS | SATYANARAYANA REDDY MANNE (IN) | 2008-05-29 | — | — | WO | claimed |
| EP-2686301-A1 | MONTELUKAST INTERMEDIATE CAMPHORSULFONIC SALT | Laboratorios Lesvi, S.L. (ES) | 2014-01-22 | — | — | EP | disclosed |
| WO-2012123506-A1 | MONTELUKAST INTERMEDIATE CAMPHORSULFONIC SALT | LABORATORIOS LESVI, S.L. (ES) | 2012-09-20 | — | — | WO | disclosed |
| WO-2012077123-A1 | PURIFICATION OF MONTELUKAST USING A SIMULATED MOVING BED | ARCH PHARMALABS LIMITED (IN) | 2012-06-14 | — | — | WO | disclosed |
| WO-2011004298-A1 | MONTELUKAST HEXAMETHYLENEDIAMINE SALT AND ITS USE FOR THE PREPARATION OF MONTELUKAST SODIUM | ALEMBIC LIMITED (IN) | 2011-01-13 | — | — | WO | disclosed |
| EP-2231613-A1 | MONTELUKAST BENZHYDRYL PIPERAZINE SALTS AND PROCESS FOR PREPARATION THEREOF | Torrent Pharmaceuticals Ltd. (IN) | 2010-09-29 | — | — | EP | disclosed |
| EP-2195295-A1 | METHOD FOR THE PREPARATION OF MONTELUKAST ACID IN IONIC LIQUID MEDIUM | Hanmi Pharm. Co., Ltd. (KR) | 2010-06-16 | — | — | EP | disclosed |
| EP-2114889-A1 | METHOD OF PREPARING MONTELUKAST AND INTERMEDIATES USED THEREIN | Hanmi Pharm. Co., Ltd. (KR) | 2009-11-11 | — | — | EP | disclosed |
| WO-2009113087-A1 | MONTELUKAST BENZHYDRYL PIPERAZINE SALTS AND PROCESS FOR PREPARATION THEREOF | TORRENT PHARMACEUTICALS LTD. (IN) | 2009-09-17 | — | — | WO | disclosed |
| WO-2009048236-A1 | METHOD FOR THE PREPARATION OF MONTELUKAST ACID IN IONIC LIQUID MEDIUM | HANMI PHARM. CO., LTD. (KR) | 2009-04-16 | — | — | WO | disclosed |
| EP-1646612-A1 | PROCESSES FOR PREPARING MONTELUKAST SODIUM | Teva Pharmaceutical Industries Ltd (IL) | 2006-04-19 | — | — | EP | disclosed |
| WO-2005105751-A1 | PROCESSES FOR PREPARING MONTELUKAST SODIUM | TEVA PHARMACEUTICAL INDUSTRIES LTD. (IL) | 2005-11-10 | — | — | WO | disclosed |
| WO-2005074893-A1 | STABLE AMORPHOUS FORMS OF MONTELUKAST SODIUM | CHEMAGIS LTD. (IL) | 2005-08-18 | — | — | WO | disclosed |
| EP-0805808-A1 | PROCESS FOR THE PREPARATION OF 1-(THIOMETHYL)-CYCLOPROPANEACETIC ACID | Merck & Co., Inc. (US) | 1997-11-12 | — | — | EP | disclosed |
| EP-0737186-A1 | PROCESS FOR THE PREPARATION OF LEUKOTRIENE ANTAGONISTS | MERCK & CO. INC. (US) | 1996-10-16 | — | — | EP | disclosed |
| EP-0737196-A1 | DIARYL 5,6-FUSED HETEROCYCLIC ACIDS AS LEUKOTRIENE ANTAGONISTS | MERCK FROSST CANADA INC. (CA) | 1996-10-16 | — | — | EP | disclosed |
| WO-1996022987-A1 | PROCESS FOR THE PREPARATION OF 1-(THIOMETHYL)-CYCLOPROPANEACETIC ACID | MERCK & CO., INC. (US) | 1996-08-01 | — | — | WO | disclosed |
| EP-0699188-A1 | QUINOLINE DERIVATIVES AS LEUKOTRIENE ANTAGONISTS | MERCK FROSST CANADA INC. (CA) | 1996-03-06 | — | — | EP | disclosed |
| WO-1995018107-A1 | PROCESS FOR THE PREPARATION OF LEUKOTRIENE ANTAGONISTS | MERCK & CO., INC. (US) | 1995-07-06 | — | — | WO | disclosed |